Increased ACE activity is caused by AngII and functional polymorphisms in the ACE gene, which increases vulnerability to asthma, pulmonary hypertension, and chronic obstructive pulmonary disease (COPD). The gene discussed is ACE; the disease is pulmonary hypertension.